Tempus AI (NASDAQ:TEM) Shares Gap Up – What’s Next?

Tempus AI, Inc. (NASDAQ:TEM) shares gapped up prior to trading on Tuesday . The stock had previously closed at $35.15, but opened at $42.84. Tempus AI shares last traded at $46.47, with a volume of 6,882,720 shares trading hands.

Wall Street Analysts Forecast Growth

A number of research firms have commented on TEM. Bank of America boosted their price objective on Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a research note on Friday, December 13th. Needham & Company LLC reissued a “buy” rating and set a $56.00 price target on shares of Tempus AI in a research note on Tuesday, January 14th. Guggenheim assumed coverage on Tempus AI in a research note on Monday, December 9th. They issued a “buy” rating and a $74.00 target price for the company. Loop Capital cut their price target on Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a research note on Tuesday, January 14th. Finally, Stifel Nicolaus downgraded shares of Tempus AI from a “buy” rating to a “hold” rating and upped their target price for the company from $45.00 to $65.00 in a research report on Monday, November 11th. Three research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $56.36.

Tempus AI Price Performance

The firm’s 50 day moving average is $45.18 and its two-hundred day moving average is $47.27. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17.

Insider Activity

In other Tempus AI news, major shareholder Bradley A. Keywell sold 265,000 shares of the stock in a transaction dated Friday, January 17th. The shares were sold at an average price of $35.10, for a total value of $9,301,500.00. Following the transaction, the insider now directly owns 15,218,365 shares of the company’s stock, valued at $534,164,611.50. This represents a 1.71 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Eric P. Lefkofsky sold 187,655 shares of the business’s stock in a transaction that occurred on Wednesday, December 18th. The stock was sold at an average price of $37.54, for a total value of $7,044,568.70. Following the sale, the chief executive officer now owns 9,557,283 shares of the company’s stock, valued at approximately $358,780,403.82. This represents a 1.93 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 1,300,761 shares of company stock valued at $51,271,197 in the last quarter.

Institutional Trading of Tempus AI

Several hedge funds have recently added to or reduced their stakes in the company. First Horizon Advisors Inc. acquired a new position in Tempus AI in the 3rd quarter valued at $30,000. FNY Investment Advisers LLC bought a new position in Tempus AI during the fourth quarter worth about $67,000. Vestor Capital LLC acquired a new stake in Tempus AI in the 3rd quarter worth about $153,000. Stifel Financial Corp bought a new stake in Tempus AI in the 3rd quarter valued at about $218,000. Finally, Sandia Investment Management LP bought a new stake in Tempus AI in the 2nd quarter valued at about $136,000. 24.22% of the stock is owned by institutional investors and hedge funds.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.